Dr. Joseph Fraiman

And we're essentially taking whoever the electric toothbrush manufacturers are.

You wouldn't do it for an electric toothbrush, you know, and yet we do it for dangerous, potentially very dangerous chemicals that we're then going to recommend to the entire population.

It's a it's pretty it's not a good idea.

during COVID, more or less.

I was at the NIH with the director, Jay Bhattacharyya.

I was a senior science strategist and helping him to get various types of policies to help improve scientific research in our country.

And at times I would be working with different agencies.

And what I'd say I found is that you have

It's very difficult within government because the way these systems have been designed, I don't know if I have a fix.

But because, for example, like the NIH, the way it's been built is over 80 years, Congress decides that we're going to have a new institute.

There's 27 institutes, 29, I believe, offices, each one with its own director.

And

This is just piled on, and it's done by Congress who aren't, they are our representatives, but I don't see how they would really know how our scientific funding system should be working.

And so, and then to fix it, you need actually an act of Congress

which I learned when I was in Washington, D.C., is just the term they use there when you say we need a change.

They say, that's an act of Congress.

And I was like, wait, that sounds impossible then.

And they're like, no, no, no, I know the guy who we're going to talk to to try to start this.

But it's quite difficult to make any sort of changes because of the system.

And that has its pluses and minuses.